We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.
Enrolling Patients in Global Phase 3 CoMpass Trial in Small Choroidal Melanoma and Indeterminate Lesions; Granted SPA Agreement by FDA Data Expected Mid-2024 from Ongoing Phase 1 Trial in Bladder...
="/Images/box-unchecked.jpg" alt="Checkbox not checked">2000003/04/2024Cash* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the...
Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today...
="/Images/box-unchecked.jpg" alt="Checkbox not checked">321101/19/2024N/A* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.58 | -6.88018979834 | 8.43 | 8.74 | 7.29 | 136227 | 8.09168839 | CS |
4 | -1.28 | -14.0197152245 | 9.13 | 9.4675 | 6.97 | 303109 | 7.75743412 | CS |
12 | -1.2 | -13.2596685083 | 9.05 | 9.72 | 6.97 | 185615 | 8.00449348 | CS |
26 | -1.41 | -15.2267818575 | 9.26 | 12.35 | 5.99 | 197041 | 8.10065739 | CS |
52 | -1.1 | -12.2905027933 | 8.95 | 13.5 | 5.99 | 133718 | 8.84475279 | CS |
156 | -6.25 | -44.3262411348 | 14.1 | 26.16 | 5.99 | 111072 | 11.62481328 | CS |
260 | -6.25 | -44.3262411348 | 14.1 | 26.16 | 5.99 | 111072 | 11.62481328 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions